Hims & Hers vs yourEra
Two GLP-1 desks, one scoreboard. We put Hims & Hers and yourEra head-to-head on the published Brief Score — the same six factors, scored the same way.
Hims & Hers
FDA warning letter, September 2025 — issued to Hims & Hers Health, Inc. dba Hims. See the FDA's warning letter database.
The verdict
Hims & Hers takes this head-to-head.
Hims & Hers scores 85 to 84 on our six-factor Brief Score — Mass-market, app-first weight program with nationwide reach — watch the compounded-supply headlines.
That doesn't make yourEra a bad call — it's best for readers who want to see the monthly number before signing up and like the option of adding nad+ or a coaching bundle later. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Hims & Hers | yourEra | |
|---|---|---|
| Brief Score | 85/100 (B) | 84/100 (B) |
| Semaglutide | $199/mo | $199/mo |
| Tirzepatide | Not disclosed | $299/mo |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
| On the tracker | Risingprice rising | Stableprice stable |
Hims & Hers: App-first reach is nationwide, but compounded supply has drawn industry-wide scrutiny.
yourEra: $199 sema / $299 tirz posted openly on-site; mid-market, but the number is right there before the quiz.
● Not sold on either?
CoreAge Rx tops the whole ranking at 94/100.
The steadiest desk in the ranking: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.